Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry

• Main Authors: Andrew Blauvelt (Author), Robert R. McLean (Author), Silky W. Beaty (Author), Adam P. Sima (Author), Robert Low (Author), Jeffrey L. Stark (Author), Laura McClung (Author), Jerry Bagel (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Due to variable psoriasis symptoms, disease progression, and individual responses to therapy, patients may start, stop, or switch biologic therapies. Real-world data on the associated disease burden of patients with psoriasis who do and do not switch biologics are incomplete. M...